BORTEZOMIB SANDOZ 3.5mg powder for solution for injection
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
letter B · page 28
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosentan Indicated for: pulmonary arterial hypertension
bosutinib Indicated for: chronic myeloid leukemia
bosutinib Indicated for: chronic myeloid leukemia